相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Association between high immune activity and worse prognosis in uveal melanoma and low-grade glioma in TCGA transcriptomic data
Hitoshi Matsuo et al.
BMC GENOMICS (2022)
Emerging roles for folate receptor FOLR1 in signaling and cancer
Fathima Zahra Nawaz et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2022)
YAP1-mediated regulation of mitochondrial dynamics in IDH1 mutant gliomas
Shruti Patrick et al.
JOURNAL OF CELL SCIENCE (2021)
YAP1 overexpression contributes to the development of enzalutamide resistance by induction of cancer stemness and lipid metabolism in prostate cancer
Hsiu-Chi Lee et al.
ONCOGENE (2021)
Chinese Glioma Genome Atlas (CGGA) : A Comprehensive Resource with Functional Genomic Data from Chinese Glioma Patients
Zheng Zhao et al.
GENOMICS PROTEOMICS & BIOINFORMATICS (2021)
Folate Receptors' Expression in Gliomas May Possess Potential Nanoparticle-Based Drug Delivery Opportunities
Eva McCord et al.
ACS OMEGA (2021)
DNA Damage-Induced Inflammatory Microenvironment and Adult Stem Cell Response
Davide Cinat et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Monoallelic IDH1 R132H Mutation Mediates Glioma Cell Response to Anticancer Therapies via Induction of Senescence
Daqian Zhan et al.
MOLECULAR CANCER RESEARCH (2021)
Radiation-induced YAP activation confers glioma radioresistance via promoting FGF2 transcription and DNA damage repair
Yu Zhang et al.
ONCOGENE (2021)
A systematic review and meta-analysis of higher expression of folate receptor alpha (FOLR1) predicts poor cancer prognosis
Yantong Liu et al.
BIOMARKERS (2020)
Understanding the glioblastoma immune microenvironment as basis for the development of new immunotherapeutic strategies
Ana Rita Pombo Antunes et al.
ELIFE (2020)
Inflammation and lymphocyte infiltration are associated with shorter survival in patients with high-grade glioma
Eliana Marinari et al.
ONCOIMMUNOLOGY (2020)
Senescent Cells in Cancer Therapy: Friends or Foes?
Boshi Wang et al.
TRENDS IN CANCER (2020)
Determining cell type abundance and expression from bulk tissues with digital cytometry
Aaron M. Newman et al.
NATURE BIOTECHNOLOGY (2019)
YAP promotes the malignancy of endometrial cancer cells via regulation of IL-6 and IL-11
Jing Wang et al.
MOLECULAR MEDICINE (2019)
Toward a better understanding of folate metabolism in health and disease
Yuxiang Zheng et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2019)
XRCC3 contributes to temozolomide resistance of glioblastoma cells by promoting DNA double-strand break repair
Wynand P. Roos et al.
CANCER LETTERS (2018)
Fatal correlation between YAP1 expression and glioma aggressiveness: clinical and molecular evidence
Pierre-Olivier Guichet et al.
JOURNAL OF PATHOLOGY (2018)
Mutant Isocitrate Dehydrogenase 1 Disrupts PKM2-beta-Catenin-BRG1 Transcriptional Network-Driven CD47 Expression
Pruthvi Gowda et al.
MOLECULAR AND CELLULAR BIOLOGY (2018)
Non-Cell Autonomous effects of the Senescence-Associated Secretory Phenotype in Cancer Therapy
Tareq Saleh et al.
FRONTIERS IN ONCOLOGY (2018)
GlioVis data portal for visualization and analysis of brain tumor expression datasets
Robert L. Bowman et al.
NEURO-ONCOLOGY (2017)
Mutant IDH1 regulates the tumor-associated immune system in gliomas
Nduka M. Amankulor et al.
GENES & DEVELOPMENT (2017)
DNA damage repair and survival outcomes in advanced gastric cancer patients treated with first-line chemotherapy
Livia Ronchetti et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Telomerase reverse transcriptase (TERT) - enhancer of zeste homolog 2 (EZH2) network regulates lipid metabolism and DNA damage responses in glioblastoma
Fahim Ahmad et al.
JOURNAL OF NEUROCHEMISTRY (2017)
Immune microenvironment of gliomas
Anna Gieryng et al.
LABORATORY INVESTIGATION (2017)
2-Hydroxyglutarate produced by neomorphic IDH mutations suppresses homologous recombination and induces PARP inhibitor sensitivity
Parker L. Sulkowski et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
YAP1 inhibition radiosensitizes triple negative breast cancer cells by targeting the DNA damage response and cell survival pathways
Daniel Andrade et al.
ONCOTARGET (2017)
Verteporfin inhibits growth of human glioma in vitro without light activation
Ahmad Al-Moujahed et al.
SCIENTIFIC REPORTS (2017)
Altered metabolic landscape in IDH-mutant gliomasaffects phospholipid, energy, and oxidative stress pathways
Fred Fack et al.
EMBO MOLECULAR MEDICINE (2017)
One-Carbon Metabolism in Health and Disease
Gregory S. Ducker et al.
CELL METABOLISM (2017)
YAP activation protects urothelial cell carcinoma from treatment-induced DNA damage
E. Ciamporcero et al.
ONCOGENE (2016)
Mutant IDH1 Downregulates ATM and Alters DNA Repair and Sensitivity to DNA Damage Independent of TET2
Satoshi Inoue et al.
CANCER CELL (2016)
Hippo pathway and protection of genome stability in response to DNA damage
Dafni E. Pefani et al.
FEBS JOURNAL (2016)
Integrin-YAP/TAZ-JNK cascade mediates atheroprotective effect of unidirectional shear flow
Li Wang et al.
NATURE (2016)
DNA damage and the balance between survival and death in cancer biology
Wynand P. Roos et al.
NATURE REVIEWS CANCER (2016)
Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas
Daniel J. Brat et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
ClustVis: a web tool for visualizing clustering of multivariate data using Principal Component Analysis and heatmap
Tauno Metsalu et al.
NUCLEIC ACIDS RESEARCH (2015)
Increased sensitivity to radiochemotherapy in IDH1 mutant glioblastoma as demonstrated by serial quantitative MR volumetry
Anh N. Tran et al.
NEURO-ONCOLOGY (2014)
The combination of IDH1 mutations and MGMT methylation status predicts survival in glioblastoma better than either IDH1 or MGMT alone
Remco J. Molenaar et al.
NEURO-ONCOLOGY (2014)
IHC Profiler: An Open Source Plugin for the Quantitative Evaluation and Automated Scoring of Immunohistochemistry Images of Human Tissue Samples
Frency Varghese et al.
PLOS ONE (2014)
Resveratrol abrogates the Temozolomide-induced G2 arrest leading to mitotic catastrophe and reinforces the Temozolomide-induced senescence in glioma cells
Eduardo C. Filippi-Chiela et al.
BMC CANCER (2013)
Inferring tumour purity and stromal and immune cell admixture from expression data
Kosuke Yoshihara et al.
NATURE COMMUNICATIONS (2013)
Use of the γ-H2AX assay to monitor DNA damage and repair in cancer research
Alesia Ivashkevich et al.
CANCER LETTERS (2012)
IDH mutations predict longer survival and response to temozolomide in secondary glioblastoma
Qi SongTao et al.
CANCER SCIENCE (2012)
Cutoff Finder: A Comprehensive and Straightforward Web Application Enabling Rapid Biomarker Cutoff Optimization
Jan Budczies et al.
PLOS ONE (2012)
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Ethan Cerami et al.
CANCER DISCOVERY (2012)
Oncometabolite 2-Hydroxyglutarate Is a Competitive Inhibitor of α-Ketoglutarate-Dependent Dioxygenases
Wei Xu et al.
CANCER CELL (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Yes-Associated Protein 1 Is Widely Expressed in Human Brain Tumors and Promotes Glioblastoma Growth
Brent A. Orr et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2011)
Enzastaurin induces H2AX phosphorylation to regulate apoptosis via MAPK signalling in malignant glioma cells
Esther P. Jane et al.
EUROPEAN JOURNAL OF CANCER (2010)
Minimally Cytotoxic Doses of Temozolomide Produce Radiosensitization in Human Glioblastoma Cells Regardless of MGMT Expression
Michael S. Bobola et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate (vol 462, pg 739, 2010)
Lenny Dang et al.
NATURE (2010)
H2AX Phosphorylation: Its Role in DNA Damage Response and Cancer Therapy
Monika Podhorecka et al.
JOURNAL OF NUCLEIC ACIDS (2010)
Diversity of DNA damage response of astrocytes and glioblastoma cell lines with various p53 status to treatment with etoposide and temozolomide
Yuichi Sato et al.
CANCER BIOLOGY & THERAPY (2009)
Isocitrate Dehydrogenase 1 Codon 132 Mutation Is an Important Prognostic Biomarker in Gliomas
Marc Sanson et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion
Francis Rodier et al.
NATURE CELL BIOLOGY (2009)
IDH1 and IDH2 Mutations in Gliomas
Hai Yan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Targeting Interleukin 6 Signaling Suppresses Glioma Stem Cell Survival and Tumor Growth
Hui Wang et al.
STEM CELLS (2009)
Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network
Thomas Kuilman et al.
CELL (2008)
TEAD mediates YAP-dependent gene induction and growth control
Bin Zhao et al.
GENES & DEVELOPMENT (2008)
Manipulation of base excision repair to sensitize ovarian cancer cells to alkylating agent temozolomide
Melissa L. Fishel et al.
CLINICAL CANCER RESEARCH (2007)
The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila homolog of YAP
JB Huang et al.
CELL (2005)
分享论文
